Compare ETFs: THNR
THNR
Comparison
Average Return
| Symbol | Year-to-date | 1 Year | 5 Years | 10 Years | Inception |
|---|---|---|---|---|---|
| THNR | 11.82% | 4.81% | - | - | 0.07% |
Top 25 Holdings
| THNR - Amplify Weight Loss Drug & Treatment ETF | |||
|---|---|---|---|
| No. | Symbol | Name | Weight |
| 1 | LLY | Eli Lilly and Company | 15.85% |
| 2 | NVO | Novo Nordisk A/S | 10.17% |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 7.88% |
| 4 | AMGN | Amgen Inc. | 7.57% |
| 5 | TYO: 4519 | Chugai Pharmaceutical Co., Ltd. | 7.22% |
| 6 | MRK | Merck & Co., Inc. | 5.58% |
| 7 | SWX: ROG | Roche Holding AG | 5.39% |
| 8 | AZN | AstraZeneca PLC | 5.20% |
| 9 | ABBV | AbbVie Inc. | 4.85% |
| 10 | PFE | Pfizer Inc. | 4.78% |
| 11 | HKG: 1801 | Innovent Biologics, Inc. | 4.45% |
| 12 | TYO: 4507 | Shionogi & Co., Ltd. | 4.32% |
| 13 | HKG: 1093 | CSPC Pharmaceutical Group Limited | 3.55% |
| 14 | HIMS | Hims & Hers Health, Inc. | 3.32% |
| 15 | CPH: ZEAL | Zealand Pharma A/S | 3.13% |
| 16 | SRRK | Scholar Rock Holding Corporation | 2.06% |
| 17 | JNGHF | Jiangsu Hengrui Pharmaceuticals Co Ltd Ordinary Shares - Class H | 1.46% |
| 18 | KRX: 128940 | Hanmi Pharm. Co., Ltd. | 1.17% |
| 19 | HKG: 3933 | The United Laboratories International Holdings Limited | 1.06% |
| 20 | AGPXX | Short-Term Investment Trust - Invesco Government & Agency Portfolio | 0.82% |
| 21 | n/a | OTHER ASSETS AND LIABILITIES | 0.13% |
| 22 | n/a | JAPANESE YEN | 0.05% |
| 23 | n/a | n/a | n/a |
| 24 | n/a | n/a | n/a |
| 25 | n/a | n/a | n/a |
| View THNR holdings | |||